Search the Newsreel

FMS Enterprises Migun Limited Revenue Breakdown – TASE:FBRT

Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients

BEACON-US research initiative is evaluating the clinical outcomes and patient experiences of high-volume hemodiafiltration in routine U.S. clinical practice across diverse patient populations Fresenius Medical Care expands access to the therapy across the U.S. building on two decades of evidence and treatment from over …

FMS|Fresenius Medical Care AG|Price:24.880|Chg%:+0.130

This article provides a comprehensive stock analysis of Fresenius Medical Care AG (FMS), highlighting its relatively healthy fundamentals, high growth potential, and fair valuation. It notes high institutional ownership and a medium-term upward trend prediction for the stock price, despite technicals not fully supporting …

Fresenius Medical Care AG & Co. KGaA (FMS) Expected to Post Quarterly Earnings on Tuesday

Fresenius Medical Care AG & Co. KGaA (FMS) is expected to release its Q2 2026 earnings before market open on Tuesday, August 4th, with analysts forecasting EPS of $0.615 and revenue of $5.484 billion. The company recently reported $1.05 EPS and $5.34 billion revenue …

Fresenius Medical Care stock trades steady as dialysis specialist focuses on margin recovery and deb

Fresenius Medical Care stock is currently undergoing a restructuring-driven turnaround, focusing on improving margins, reducing net debt, and streamlining its core dialysis services. The company's financial reports highlight progress in efficiency measures, cost savings, and deleveraging efforts, which are crucial for attracting investors who …

FMC stock trades steadily as Fresenius Medical Care focuses on margin and cash flow improvements

Fresenius Medical Care (FMC) stock is being closely watched as the company prioritizes improving profitability and cash generation amidst challenges like reimbursement pressure and rising labor costs. The global dialysis specialist's revenue is driven by its dialysis services and products, with investors analyzing treatment …

FMC stock trades steady as Fresenius Medical Care updates earnings outlook

Fresenius Medical Care (FMC) stock is trading steady following the company's updated earnings outlook, driven by consistent growth in dialysis services and products. The company reported a significant increase in net income and revenue for fiscal year 2025, along with positive guidance for 2026, …

FMC stock trades steady as Fresenius Medical Care updates guidance and focuses on dialysis margins

Fresenius Medical Care (FMC) stock is trading steadily after the company updated its earnings guidance and focused on enhancing dialysis margins. The article details FMC's revenue growth, shifting profitability mix across regions, and the influence of updated guidance and earnings metrics on its stock …

Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...

This article first appeared on GuruFocus. Release Date: July 23, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Quest Diagnostics Inc (NYSE:DGX) reported a strong revenue growth of over 10% in the second …

Fresenius Medical Care stock trades steady as Q1 2026 turnaround plan supports margins

Fresenius Medical Care's Q1 2026 results show lower revenue but improved operating margins, driven by cost-efficiency measures and portfolio adjustments in its ongoing turnaround plan. Despite a challenging reimbursement and labor environment, the company achieved net income growth, underscoring the effectiveness of its restructuring …

FMC stock trades steady as Fresenius Medical Care focuses on profitability and debt reduction

Fresenius Medical Care (FMC) stock is trading steadily as the company prioritizes profitability and debt reduction. Recent financial data indicate modest revenue growth, improved operating margins by 1-2 percentage points, and a reduction in net debt to EBITDA from 3.5x to around 3.0x. The …

Fresenius Medical Care stock reacts to restructuring progress as earnings stabilize

Fresenius Medical Care's stock is under investor scrutiny on Xetra as the company continues its multi-year restructuring program. The company aims to stabilize earnings and cash flow over 2024 and 2025, driven by cost discipline and consistent dialysis demand. Efforts include stream lining operations, …

FMC stock trades steady as Fresenius Medical Care focuses on margin recovery and dialysis demand

Fresenius Medical Care (FMC) stock is holding steady as the company works to improve profitability amidst challenges in the dialysis sector. The article discusses FMC's dual business model of dialysis services and product manufacturing, highlighting the factors influencing revenue, margins, and investor perception. It …

Jefferies Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Jefferies analyst James Vane has reiterated a Sell rating for Fresenius Medical Care AG & Co. KGaA (0H9X), setting a price target of €31.00. This follows similar Sell ratings from Bank of America Securities, while Citi maintained a Hold rating on July 17. The …

Fresenius Medical Care: More Favorable Patient Outcomes Will Drive Growth (NYSE:FMS)

Fresenius Medical Care stock trades steady as dialysis group highlights margin recovery and stable c

The article discusses Fresenius Medical Care stock, focusing on the company's efforts to highlight margin recovery and stable cash flow in its dialysis business. It delves into revenue and earnings trends, margin comparisons, segment performance, balance sheet strength, and the impact of restructuring initiatives. …

Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy

Cloud-based platform provides retrospective, program-level insight into kidney replacement therapy delivered in acute and hospital critical care settings Available within NxStage® System One™ with NxView™ 4.0, Fresenius Medical Care's FDA 510(k)-cleared software platform for kidney replacement therapy in the United States Aggregates existing therapy …

FMC stock trades steady as Fresenius Medical Care updates guidance and margin focus

Fresenius Medical Care (FMC) is focusing on improving profitability, with updated fiscal 2024 guidance projecting adjusted operating income growth of 5-15% despite revenue growth of only 0-3%. This strategic shift emphasizes operational efficiency, cost control, and margin expansion in its dialysis services and product …

Fresenius Medical Care stock trades around multi month low as restructuring and dividend follow weak 2023 earnings

Fresenius Medical Care's stock is trading near a multi-month low due to challenging 2023 earnings, which saw a significant decline in net income and a reduced dividend. The company's revenue increased slightly to over EUR 19 billion, driven by stable demand for dialysis services, …

Fresenius Medical Care stock stabilizes as cost measures support earnings outlook

Fresenius Medical Care's stock is stabilizing as the company's cost measures and restructuring efforts begin to support its earnings outlook. Despite past pressures from inflation and labor costs, the global leader in dialysis services is focusing on improving efficiency and optimizing its operations. Long-term …

FMC stock trades steadily as Fresenius Medical Care focuses on profitability and transformation

Fresenius Medical Care (FMC) is focusing on improving profitability and operational efficiency in its global dialysis business, which is reflected in the steady trading of its stock. Recent quarterly figures show enhanced efficiency, driven by cost-control programs and portfolio optimization, despite moderate revenue growth. …

Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from J.P. Morgan

J.P. Morgan analyst David Adlington has reiterated a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X) with a price target of €37.40. This rating aligns with the overall analyst consensus of Moderate Sell for the company. Fresenius Medical Care AG & …

Fresenius Medical Care stock trades steady as turnaround efforts focus on margins and debt reduction

Fresenius Medical Care is undergoing a multi-year turnaround, with recent 2023 results showing rising revenue, improving margins, and targeted debt reduction. The company reported annual revenue of approximately EUR 19 billion and is focused on stabilizing operating profitability, evidenced by an adjusted operating result …

FMC stock trades steady as Fresenius Medical Care refines focus and margins

The article discusses how Fresenius Medical Care (FMC) stock performance is tied to the company's efforts in balancing dialysis growth, margin improvement, and capital discipline. It highlights revenue trends from global dialysis operations, profitability and margin comparisons, and the importance of balance sheet strength …

FMS Enterprises Migun Limited Cash Flow – TASE:FBRT